hyperglycemic emergencies
play

Hyperglycemic Emergencies Diabetic Ketoacidosis and Hyperosmolar - PowerPoint PPT Presentation

Hyperglycemic Emergencies Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State Jordanna Kapeluto and Evelyn Wong PGY-5 Endocrinology June 10/June 28, 2015 J Kapeluto 2015 Learning Objectives Definition and Physiology of Diabetic


  1. Hyperglycemic Emergencies Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State Jordanna Kapeluto and Evelyn Wong PGY-5 Endocrinology June 10/June 28, 2015

  2. J Kapeluto 2015 Learning Objectives • Definition and Physiology of Diabetic Hyperglycemia Syndromes • Causes of Diabetic Hyperglycemia Syndromes • Management of DKA/HSS • Special Considerations in DKA 1

  3. J Kapeluto 2015 Abbreviations in this session Abbr Term Abbr Term DKA Diabetic ketoacidosis Na Sodium HHS Hyperglycemic K Potassium hyperosmolar state AG Anion gap T1DM Type 1 diabetes mellitus AGMA Anion gap metabolic T2DM Type 2 diabetes mellitus acidosis SGLT2 Sodium glucose BUN Blood urea nitrogen transporter 2 Osm Osmolality ECG Electrocardiogram NS Normal saline AXR Abdominal x-ray LBW Lean body weight IVF Intravenous fluids HF-PEF Heart failure with HF-REF Heart failure with reduced preserved ejection fraction ejection fraction u/o Urine output ABG Arterial blood gas 2

  4. J Kapeluto 2015 Epidemiology DKA HHS Population Type 1 (2/3) Type 2 Type 2 (1/3) Incidence 4.6 – 8.0 per 1000 < 1 per 1000 person-years person-years Morbidity 5000 – 10 000 500 – 1000 hospitalizations hospitalizations Mortality 4 – 10% 10 – 50% Recurrent DKA:  all- Underlying illness cause mortality 30% Fishbein et al. Diabetes in America. 1995. 3 Chiasson et al. CMAJ. 2003.

  5. J Kapeluto 2015 Clinical Presentation DKA DKA HHS • ฀ skin turgor • • (Polyuria) Polyuria • • Dry axillae • (Polydipsia) Polydipsia Chronic • Dry oral mucosa • • (Weight loss) Weight loss • ฀ JVP • Volume depletion Severity • Tachycardia • Vomiting • Hypotension • Volume depletion • Neurologic Acute – Lethargy • Ketone breath – Coma • Abdominal pain • Kussmaul – Hemianopsia • breathing Hyperventilation – Hemiparesis – Seizures Kitabchi A et al. Diab Care. 2009 4

  6. J Kapeluto 2015 Physiology of Hyperglycemia Chiasson et al. CMAJ. 2003. 5

  7. J Kapeluto 2015 Diagnosis – Diabetic Ketoacidosis + + Hyperglycemia* Ketones Acidosis • • • > 13.9 mmol/L Acetoacetic acid AGMA • • • [Euglycemic DKA] Beta- pH < 7.35 • hydroxybutyric acid AG >12 • • +/- ฀ lactate Acetone • Resp alkalosis 6

  8. J Kapeluto 2015 Diagnosis – Diabetic Ketoacidosis DKA Mimickers Ketones AGMA • • Starvation (HCO3 >18) Lactic acidosis • • Alcohol Toxicities • Acute/chronic renal failure Kitabchi A et al. Diab Care. 2009 6

  9. J Kapeluto 2015 Management – Issues Volume Acidosis Ketosis Hyperglycemia Underlying Potassium Sodium Cause 7

  10. J Kapeluto 2015 Management Volume 8

  11. J Kapeluto 2015 Step 1 – Volume • Hyperglycemia ⬆ osmotic diuresis ⬆ volume depletion • Average fluid deficit: 3-6L • Replacement: • Hemodynamic stability • Start with NS (0.9% NaCl) • 500-1000 cc/hr (15-20cc/kg/hr) x 1 hour • Full replacement over 24 hours • Reassess using JVP/volume status q1h initially and Na • (Dextrose) Kitabchi A et al. Diab Care. 2009 9

  12. J Kapeluto 2015 Step 1 – Volume • Cerebral edema? • More common in patients <20 years (0.3-1%) • Can occur in adults • Mortality 20-40% • DKA >>> HHS • Pathophysiology unknown • Often present prior to therapy • First 12-24 hours • Monitor: headache  lethargy, decreased arousal  seizures, incontinence, pupillary changes, bradycardia, and respiratory arrest Kitabchi A et al. Diab Care. 2009 10

  13. J Kapeluto 2015 Step 1 – Volume • Prevention of (worsening) cerebral edema • • DKA HHS • • Cautious fluid replacement Same as DKA • • 15-20 cc/kg LBW/hr Add dextrose in IVF to maintain serum glucose 13.9-16.7 mmol/L • Maximum <50cc/kg in first 2-3 • hours Maintain serum glucose until hyperosmolality improving and • Dextrose in IVF once serum mental status/clinically stable glucose reaches 11.1 mmol/L • Pulmonary edema – Non-cardiogenic: due to reduction colloid osmotic pressure – Cardiogenic: caution with IVF in oligo/anuric CKD and HF-PEF/HF-REF Kitabchi A et al. Diab Care. 2009 11

  14. J Kapeluto 2015 Monitoring Volume Time 0 6 12 18 24 pH Ketones Kitabchi A et al. Diab Care. 2009 12

  15. J Kapeluto 2015 Management Volume Potassium Volume 13

  16. J Kapeluto 2015 Step 2 - Potassium • Insulin deficiency + acidosis ⬆ extra cellular shift K + urinary losses • Total K deficit 3-5 mEq/kg • Renal function – u/o 50 cc/hr K < 3.3 K 3.4-4.9 K > 5.0-5.2 • • • Do not start insulin IVF 10-40 mmol/L Monitor K until K > 3.3 • IVF 40 mmol/L • Monitor q2h initially then q4h, choose venous or ABG • PO or central IV if K decreasing with IVF • Caution with K replacement in CKD – rarely hypoK Kitabchi A et al. Diab Care. 2009 14

  17. J Kapeluto 2015 Monitoring Potassium Volume Time 0 6 12 18 24 pH Ketones 15

  18. J Kapeluto 2015 Management Volume Potassium Insulin Volume 16

  19. J Kapeluto 2015 Step 3 – Insulin • Insulin deficiency ฀ hyperglycemia + ketosis • Insulin therapy – treating the acidosis NOT hyperglycemia • Bolus vs. No bolus – No benefit to bolus – Theoretical large intracellular shift in potassium • Insulin R IV 0.1-0.15 units/kg LBW/hr to start – Average 70 kg person = 7 units/hr Kitabchi A et al. Diab Care. 2009 17

  20. J Kapeluto 2015 Step 3 – Insulin • Monitoring insulin therapy in DKA • CBG measurements q1h + venous with other electrolytes • IVF lowers sugars ฀ can have rapid decrease in glucose within first hours of treatment – increased renal perfusion and glycosuria – dilutional effect • Do not stop insulin if glucose low – start dextrose (D5 + IVF) and reduce rate of insulin or give insulin 0.1 units/kg SC q2h – DKA: CBG 11.1 mmol/L – HHS: CBG 16.7 mmol/L Kitabchi A et al. Diab Care. 2009 18

  21. J Kapeluto 2015 Step 3 – Insulin • Monitoring acidosis in DKA • Calculate the anion gap with each measurement of electrolytes AG = Na – (Cl + HCO 3 ) • Bicarbonate – IV bicarbonate = controversial – pH <6.9 100 mmol sodium bicarbonate (two amps) in 400 cc sterile water + 20 mEq KCI at 200 cc/hr for 2 h – Stop when pH >7.0 – Monitor K Kitabchi A et al. Diab Care. 2009 19

  22. J Kapeluto 2015 Monitoring AG orHCO3 Glucose Potassium Volume Time 0 6 12 18 24 pH Ketones 20

  23. J Kapeluto 2015 Management Volume Potassium Sodium Volume Insulin 21

  24. J Kapeluto 2015 Step 4 – Sodium • Hyperglycemia + fluid shifts ฀ sodium disturbances – Hypernatremia = indicates severe volume depletion – Hyponatremia = most common – Pseudohyponatremia = lab artifact/dilutional effect from hyperglycemia • Total Na also depleted 7-10 mEq/kg Correction calculation: +3 mmol/L Na for every 10 mmmol/L of glucose above 10 • Monitor q2h initially then q4h • Adjust IVF from NS to 1/2 NS if overcorrecting hypoNa Kitabchi A et al. Diab Care. 2009 22

  25. J Kapeluto 2015 Monitoring AG orHCO3 Sodium Glucose Potassium Volume Time 0 6 12 18 24 pH Ketones 23

  26. J Kapeluto 2015 Management Volume Sodium Potassium Precipitant Volume Insulin 24

  27. J Kapeluto 2015 Step 5 – Causes of DKA Insulin deficiency 25

  28. J Kapeluto 2015 Step 5 – Causes of DKA • New T1DM Insulin deficiency • Adherence 25

  29. J Kapeluto 2015 Step 5 – Causes of DKA • New T1DM • (C-peptide levels) Insulin deficiency • Adherence 25

  30. J Kapeluto 2015 Step 5 – Causes of DKA • (C-peptide levels) Iatrogenic 25

  31. J Kapeluto 2015 Step 5 – Causes of DKA • (C-peptide levels) • Medications Iatrogenic • Glucocorticoids 25

  32. J Kapeluto 2015 Step 5 – Causes of DKA • (C-peptide levels) • Medications Iatrogenic • Glucocorticoids • Thiazide diuretics • Sympathomimetics • Lithium • Cocaine • Atypical antipsychotics • Fluoroquinolones • Prednisone • Dexamethasone • Hydrocortisone 25

  33. J Kapeluto 2015 Step 5 – Causes of DKA • (C-peptide levels) • Urine toxin screen • Medications Iatrogenic • Glucocorticoids • Thiazide diuretics • Sympathomimetics • Lithium • Cocaine • Atypical antipsychotics • Fluoroquinolones • Prednisone • Dexamethasone • Hydrocortisone 25

  34. J Kapeluto 2015 Step 5 – Causes of DKA • (C-peptide levels) • Urine toxin screen • Bacterial > viral > Infection fungal 25

  35. J Kapeluto 2015 Step 5 – Causes of DKA • (C-peptide levels) • Urine toxin screen • Bacterial > viral > Infection fungal ICU Setting (n=40) Type: 1. Urinary 2. Gastrointestinal Pathogens: 1. E. coli 2. Staph aureus 3. Klebsiella pneumoniae Azoulay E et al. Clin Infect Dis. 2001 25

  36. J Kapeluto 2015 Step 5 – Causes of DKA • (C-peptide levels) • Urine toxin screen • Blood cultures • Urine cultures • Bacterial > viral > Infection • Respiratory cultures fungal • Wound/Bone biopsy ICU Setting (n=40) Type: 1. Urinary 2. Gastrointestinal Pathogens: 1. E. coli 2. Staph aureus 3. Klebsiella pneumoniae Azoulay E et al. Clin Infect Dis. 2001 25

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend